AntiCoagulation Europe (UK)

ABOUT US

Contact us

ANTIPLATELET THERAPY

Educational Films

About Antiplatelet therapy


Antiplatelets

Platelets are blood cells that help the blood clot and prevent bleeding. When you cut yourself platelets begin to work and help your blood to clot and stop you bleeding.

Antiplatelet drugs are a group of powerful medications that prevent the formation of blood clots. They are effective in the arterial circulation, where anticoagulants have little effect.Image: blood cells

When you are wounded, platelets arrive on the scene and group together, forming a blood clot that stops the bleeding. In many situations, this is a good thing, but platelets can also cause clots to form in an already injured or stressed artery and these clots may lead to a transient ischaemic attack (TIA) or a stroke. Antiplatelet medications can help to prevent this process from occurring.

Aspirin is the most common antiplatelet drug. Another commonly used antiplatelet drug is Plavix (Clopidogrel).


How are antiplatelets taken?

Antiplatelets are tablets that are usually taken once or twice a day. They should not be taken on an empty stomach.

People with bleeding problems or ulcers, should talk to their doctor before taking these drugs, as they may cause excessive bleeding.

Always read the labels of other pain relievers and cold products to make sure they are aspirin-free. Medicines containing aspirin or non-steroidal anti-inflammatory drugs may cause bleeding problems when taken along with antiplatelet drugs.

Always tell the pharmacist (chemist) what medication you are taking before buying over the counter medicines, vitamins or herbal remedies.

Before any surgical or dental procedure or emergency treatment, tell the doctor or dentist that you are taking this medicine.

Always carry some form of medical alert system that tells others that you are on antiplatelet therapy. This may be vital in case of an accident where you are unconscious and bleeding.

You should not stop taking your antiplatelet medications unless advised by your doctor.


For what conditions are antiplatelet drugs prescribed?

Antiplatelets may be prescribed for patients with a history of: Image: man thinking

  • Coronary artery disease
  • Heart attack
  • Angina (chest pain)
  • Stroke and transient ischaemic attacks (TIAs)
  • Peripheral artery disease (PAD)

Antiplatelets may also be prescribed:

  • After angioplasty and stent placement.
  • After heart bypass surgery.
  • To prevent the formation of blood clots in people with atrial fibrillation.

Always discuss with your doctor which treatment, antiplatelet or anticoagulant therapy, will be best for your condition.

anticoagulation@ntlworld.com

Copyright AntiCoagulation Europe 2006
Registered Charity No 1090250

Text too small? Click here.

AntiCoagulation Europe, PO Box 405, Bromley, Kent BR2 9WP | Tel: 020 8289 6875


PLEASE NOTE THIS WEBSITE SHOULD NOT BE USED TO REPLACE ADVICE FROM YOUR DOCTOR


We welcome feedback about our website. Please email your comments to
anticoagulation@ntlworld.com

 

Contact us by email

 

Contact us by post, phone or fax

 

What is atrial fibrillation?

 

About Cardioversion

 

ABout Ablation

 

Lionel

 

TIPS TO HELP YOU AVOID A DVT

 

TRAVELLER'S THROMBOSIS

 

Stress and heart disease

 

Medical Alert identity Card

 

MARIANNE GILL

 

John Kelman

 

MICHAEL KNIGHT

 

Evelyn Richardson

 

Max Crompton

 

1. Introduction

 

2. Overview

 

3. How to Roll out a near-patient testing service in Primary care

 

4. The importance of quality control and assurance and Selecting a POC device

 

5. Rolling out a Patient self-testing service

 

6. The patient's perspective

 

7. A personal account

 

8. Conclusion

 

European Medicines agency recommends approval of Dabigatran etexilate

 

UNipath withdraws smartchek

 

A guide to setting up Near Patient Testing in Primary Care

 

NICE guidelines for atrial fibrillation

 

Near patient Testing in Tayside

 

Patients capable of self-testing: a systematic review

 

European Medicines agency recommends approval of Dabigatran etexilate

 

UNipath withdraws smartchek

 

NICE guidance on Venous Thromboembolism (VTE)

 

Venous thromboembolism CMO press release

 

Front Line in Stroke Prevention - Report

 

New hope for early detection of deep vein thrombosis

 

NICE guidelines for atrial fibrillation

 

Ongoing trials for new oral anticoagulant

 

Expert pharmacists get the go-ahead

 

Patients capable of self-testing: a systematic review

 

News archive

 

'Strips on prescription' resource pack

 

Abolition of prescription charges

 

Equality for the Republic of Ireland

 

It's about time

 

It's about time survey

 

Conference 2008

 

Flora London MArathon 2008

 

CoaguNation Bus Tour

 

Roche Diagnostics launches CoaguNation Club

 

INR Test Monitors

 

Breaking news